Diagnostic Performance of Serum Endocan in Diagnosis of Organ Failure in Hospitalized Cirrhotic Patients

Recruiting

• Conditions: Organ failures in hospitalized cirrhotic patients; ESM1 protein, human; Procalcitonin; Interleukin-6; Acute-on-chronic liver failure; Liver Cirrhosis

• Registration Number: TCTR20220415001
• Lead Sponsor: iver Research Unit, Chulalongkorn University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2022-04-14
• Study Start: 2022-04-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 115

Inclusion Criteria

1. Hospitalized cirrhotic patients

Exclusion Criteria

1. Active cancer within 2 years prior to participation
2. Myocardial infarction with 50% stenosis in one of major vessels
3. Chronic kidney disease stage V
4. Chronic obstructive pulmonary disease
5. Pervious participation in this study and had readmission

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Organ failure at recruitment ACLF criteria by EASL guideline

Secondary Outcome Measures

Name	Time	Method
Organ failure within 90 days after recruitment ACLF criteria by EASL guideline,Mortality within 90 days after recruitment Death